Business Description
Vera Therapeutics Inc
NAICS : 325412
SIC : 2834
ISIN : US92337R1014
Share Class Description:
VERA: Class ADescription
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.43 | |||||
| Equity-to-Asset | 0.78 | |||||
| Debt-to-Equity | 0.19 | |||||
| Debt-to-EBITDA | -0.44 | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 45 | |||||
| 3-Year EPS without NRI Growth Rate | 43.6 | |||||
| 3-Year FCF Growth Rate | 36.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -13.4 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 66.95 | |||||
| 9-Day RSI | 61.51 | |||||
| 14-Day RSI | 59.69 | |||||
| 6-1 Month Momentum % | 10.72 | |||||
| 12-1 Month Momentum % | 217.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 13.76 | |||||
| Quick Ratio | 13.76 | |||||
| Cash Ratio | 13.35 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -29.5 | |||||
| Shareholder Yield % | -10.34 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -56.18 | |||||
| ROA % | -43.73 | |||||
| ROIC % | -2478.5 | |||||
| ROC (Joel Greenblatt) % | -4130.52 | |||||
| ROCE % | -44.6 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 9.3 | |||||
| Price-to-Tangible-Book | 9.3 | |||||
| EV-to-EBIT | -21.22 | |||||
| EV-to-Forward-EBIT | -20.09 | |||||
| EV-to-EBITDA | -21.48 | |||||
| EV-to-FCF | -22.44 | |||||
| Price-to-Net-Current-Asset-Value | 9.44 | |||||
| Price-to-Net-Cash | 9.81 | |||||
| Earnings Yield (Greenblatt) % | -4.71 | |||||
| FCF Yield % | -3.9 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:VERA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Vera Therapeutics Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -2.61 | ||
| Beta | 1.18 | ||
| Volatility % | 140.03 | ||
| 14-Day RSI | 59.69 | ||
| 14-Day ATR ($) | 2.579248 | ||
| 20-Day SMA ($) | 46.97 | ||
| 12-1 Month Momentum % | 217.54 | ||
| 52-Week Range ($) | 13.01 - 51.61 | ||
| Shares Outstanding (Mil) | 63.32 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Vera Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Vera Therapeutics Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Vera Therapeutics Inc Frequently Asked Questions
What is Vera Therapeutics Inc(VERA)'s stock price today?
The current price of VERA is $48.83. The 52 week high of VERA is $51.61 and 52 week low is $13.01.
When is next earnings date of Vera Therapeutics Inc(VERA)?
The next earnings date of Vera Therapeutics Inc(VERA) is 2025-02-07 Est..
Does Vera Therapeutics Inc(VERA) pay dividends? If so, how much?
Vera Therapeutics Inc(VERA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers